Style | Citing Format |
---|---|
MLA | Pakdel FD, et al.. "A Novel Approach for Development of Intraocular Biodegradable Ranibizumab Implant: A Solution for Stability of Protein Activity." Advanced Pharmaceutical Bulletin, vol. 11, no. 4, 2021, pp. 632-642. |
APA | Pakdel FD, Mirshahi A, Zahedi P, Mohammad K, Hemmati F, Pakdel JD, Nicknam MH, Dorkoosh FA (2021). A Novel Approach for Development of Intraocular Biodegradable Ranibizumab Implant: A Solution for Stability of Protein Activity. Advanced Pharmaceutical Bulletin, 11(4), 632-642. |
Chicago | Pakdel FD, Mirshahi A, Zahedi P, Mohammad K, Hemmati F, Pakdel JD, Nicknam MH, Dorkoosh FA. "A Novel Approach for Development of Intraocular Biodegradable Ranibizumab Implant: A Solution for Stability of Protein Activity." Advanced Pharmaceutical Bulletin 11, no. 4 (2021): 632-642. |
Harvard | Pakdel FD et al. (2021) 'A Novel Approach for Development of Intraocular Biodegradable Ranibizumab Implant: A Solution for Stability of Protein Activity', Advanced Pharmaceutical Bulletin, 11(4), pp. 632-642. |
Vancouver | Pakdel FD, Mirshahi A, Zahedi P, Mohammad K, Hemmati F, Pakdel JD, et al.. A Novel Approach for Development of Intraocular Biodegradable Ranibizumab Implant: A Solution for Stability of Protein Activity. Advanced Pharmaceutical Bulletin. 2021;11(4):632-642. |
BibTex | @article{ author = {Pakdel FD and Mirshahi A and Zahedi P and Mohammad K and Hemmati F and Pakdel JD and Nicknam MH and Dorkoosh FA}, title = {A Novel Approach for Development of Intraocular Biodegradable Ranibizumab Implant: A Solution for Stability of Protein Activity}, journal = {Advanced Pharmaceutical Bulletin}, volume = {11}, number = {4}, pages = {632-642}, year = {2021} } |
RIS | TY - JOUR AU - Pakdel FD AU - Mirshahi A AU - Zahedi P AU - Mohammad K AU - Hemmati F AU - Pakdel JD AU - Nicknam MH AU - Dorkoosh FA TI - A Novel Approach for Development of Intraocular Biodegradable Ranibizumab Implant: A Solution for Stability of Protein Activity JO - Advanced Pharmaceutical Bulletin VL - 11 IS - 4 SP - 632 EP - 642 PY - 2021 ER - |